Group 1 - The core viewpoint of the article highlights the increasing trend of A-share companies seeking to list on both A and H stock markets, with a notable surge expected starting from Q4 2024 [1][6][7] - Wolong Nuclear Materials (沃尔核材) announced plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [1] - Other A-share companies such as Saisir (赛力斯), Zhaowei Electromechanical (兆威机电), and Dongpeng Beverage (东鹏饮料) have also recently announced intentions to list in Hong Kong [1][6] Group 2 - Wolong Nuclear Materials reported a significant increase in revenue and net profit for 2024, with revenue reaching 6.93 billion yuan, up 21.0% year-on-year, and net profit of 848 million yuan, also up 21.0% [3] - In Q1 2024, the company achieved revenue of 1.76 billion yuan, a 26.6% increase year-on-year, and a net profit of 250 million yuan, up 35.9% [3] - Despite strong overall performance, the company experienced a decline in gross profit margins for its new energy products, with a decrease of 4.37% for power products, 3.06% for new energy vehicles, and 1.96% for wind power products [3][4] Group 3 - The article notes that many A-share companies are pursuing H-share listings to expand internationally, with companies like Heng Rui Pharmaceutical (恒瑞医药) and Bai Li Tianheng (百利天恒) citing enhanced global brand influence and funding for international operations as key motivations [8] - Deloitte predicts that around 80 new stocks will enter the Hong Kong market in 2025, raising between 130 billion to 150 billion HKD [8] - The liquidity and valuation of Hong Kong stocks have improved since September 2022, creating favorable conditions for A-share companies to list in Hong Kong [8]
沃尔核材赴港上市 下半年或迎“A+H”潮